Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Eric Lehr

Thoracic Surgery (Cardiothoracic Vascular Surgery) Seattle, WA Medical Doctor

NPI 1265693154 CMS profile 103167

1600 E Jefferson St, Ste 110, Seattle, WA 98122

Open in the dashboard

General payments

$71,751

201 records reported · program years 2019–2025

Research payments

$21,125

Paid to them · 35 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$426,336 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Eric Lehr of Seattle, WA is reported in the CMS Open Payments database as having received $71,751 across 201 general payments and $21,125 in research payments paid to them. Separately, studies naming them as principal investigator received $426,336 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 93rd percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

14 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $8,447 19
2025 Research $3,000 3
2024 General $22,339 46
2024 Research $875 2
2023 General $6,194 37
2023 Research $7,100 5
2022 General $22,178 36
2022 Research $4,550 7
2021 General $7,732 24
2021 Research $2,100 6
2020 General $190 3
2020 Research $1,925 6
2019 General $4,672 36
2019 Research $1,575 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Eric Lehr
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Eric Lehr were reported at $8,447. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Eric Lehr Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $4,672 $886 $178–$3,167 $163
2020 $190 $341 $108–$1,605 $114
2021 $7,732 $453 $125–$1,886 $132
2022 $22,178 $695 $180–$2,566 $149
2023 $6,194 $745 $205–$2,662 $160
2024 $22,339 $799 $214–$2,967 $164
2025 $8,447 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Atricure, Inc. $38,138 64 payments
  2. Medtronic, Inc. $24,643 66 payments
  3. Boston Scientific Corporation $2,431 14 payments
  4. Medela AG $1,500 1 payment
  5. Edwards Lifesciences Corporation $1,447 21 payments
  6. Abbott Laboratories $955 12 payments
  7. AngioDynamics, Inc. $935 3 payments
  8. Invictus Surgical Incorporated $840 4 payments
  9. Abiomed $382 7 payments
  10. Arthrex, Inc. $303 3 payments
  11. Other $176 6 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $24,725 9 payments
  2. Travel and Lodging $24,349 52 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $13,350 7 payments
  4. Food and Beverage $9,240 131 payments
  5. Education $87 2 payments
Products named General payments · program years 2019–2025
  1. SYNERGY ABLATION SYSTEM $24,228 24 payments
  2. ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2) $12,873 7 payments
  3. Avalus $11,389 18 payments
  4. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX $6,705 16 payments
  5. Cardioblate $5,040 28 payments
  6. Simulus $2,850 10 payments
  7. CARDIOBLATE CRYOFLEX $2,400 1 payment
  8. Penditure $2,292 4 payments
  9. General Therapies $2,215 11 payments
  10. ATRICLIP LAA EXCLUSION SYSTEM $2,153 17 payments
  11. Other $6,543 59 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic, Inc. $17,625 23 payments
  2. Medtronic Vascular, Inc. $3,500 12 payments

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

16

Median for Cardiac Surgery: 68

Drug cost

$70

Median for Cardiac Surgery: $445

Branded share of claims

0%

Median for Cardiac Surgery: 15.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Chlorhexidine Gluconate Generic 16 $70

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 411 Part D prescribers listed as Cardiac Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 67 billing codes

Paid by Medicare

$211,755

Medicare's payments for the services billed

Medicare patients

146

Average age 77

Services billed

394

57 women, 89 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Heart failure 75%
Ischemic heart disease 66%
Atrial fibrillation 62%
Arthritis 51%
Chronic kidney disease 33%
Diabetes 29%
COPD 17%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

236 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in Washington

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record